-+ 0.00%
-+ 0.00%
-+ 0.00%

ARGENX, a global biopharmaceutical company headquartered in Amsterdam, the Netherlands, will acquire FORTE BIOSCIENCES in cash of $77 per share.

Zhitongcaijing·07/27/2026 05:09:04
Listen to the news
ARGENX, a global biopharmaceutical company headquartered in Amsterdam, the Netherlands, will acquire FORTE BIOSCIENCES in cash of $77 per share.